ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Kite Pharma, Inc.

Kite Pharma, Inc. (KITE)

179.79
0.00
( 0.00% )
更新日時: 09:00:00

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
179.79
買値
107.00
売値
179.99
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
179.79
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

KITE 最新ニュース

Gilead Sciences Completes Acquisition of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Dodgers Merger Sub, Inc., a wholly-owned subsidiary of Gilead (“Purchaser”...

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of the tender offer by its wholly-owned subsidiary, Dodgers Merger Sub, Inc. (“Purchaser”), for all of the...

Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period

Gilead Sciences, Inc. (Nasdaq: GILD) and Kite Pharma, Inc. (Nasdaq: KITE) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE PR Newswire NEW YORK, Aug. 31, 2017 NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Juan...

Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc.

Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc. PR Newswire NEW YORK, Aug. 29, 2017 NEW YORK, Aug. 29, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kite Pharma, Inc.

Rowley Law PLLC is investigating potential claims against Kite Pharma, Inc. (NASDAQ: KITE) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of...

Gilead Sciences to Acquire Kite Pharma for $11.9 Billion

-- Immediately Positions Gilead as a Leader in Cell Therapy -- -- Kite’s Lead CAR T Therapy Candidate, Axicabtagene Ciloleucel, Under Priority Review in the U.S. and Expedited Review in...

Kite Highlights Publication from the National Cancer Institute Demonstrating Responses in Patients with Metastatic Solid Tumo...

Study Demonstrates the Potential of TCR Engineered T-Cell Therapy to Induce Remissions in Solid Tumors KITE-718, Utilizing Same TCR Construct and Next-Generation T-Cell Manufacturing...

Kite Reports Second Quarter 2017 Financial Results

Filed Industry’s First CAR-T Marketing Authorization Application in Europe for Axicabtagene Ciloleucel for Potential EU Approval and Launch in 2018 Submitted Investigational New Drug...

Kite Submits Investigational New Drug (IND) Application for KITE-585, Anti-BCMA CAR-T Therapy Candidate for Multiple Myeloma

Internally Generated Cell Therapy Candidate Engineered with Fully Human Anti-BCMA Construct Next-Generation Manufacturing Process Designed for Enhanced Product Potency and Activity...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

KITE - Frequently Asked Questions (FAQ)

What is the current KITE PHARMA, INC. share price?
The current share price of KITE PHARMA, INC. is US$ 179.79
What is the 1 year trading range for KITE PHARMA, INC. share price?
KITE PHARMA, INC. has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ASSTAsset Entities Inc
US$ 1.0289
(121.51%)
91.4M
HSDTHelius Medical Technologies Inc
US$ 1.4099
(87.74%)
58.06M
INMInMed Pharmaceuticals Inc
US$ 6.94
(40.20%)
12.96M
EOLSEvolus Inc
US$ 13.50
(28.45%)
256.48k
LEDSSemiLEDS Corporation
US$ 2.12
(26.12%)
4.92M
GOEVCanoo Inc
US$ 0.3784
(-71.97%)
5.99M
TOIIWOncology Institute Inc
US$ 0.013
(-35.00%)
26.97k
SHOTWSafety Shot Inc
US$ 0.1525
(-26.68%)
600
FTAIFTAI Aviation Ltd
US$ 83.14
(-26.02%)
1.97M
ORKTOrangeKloud Technology Inc
US$ 0.85
(-24.11%)
2.04M
CRKNCrown Electrokinetics Corporation
US$ 0.144
(15.20%)
131.24M
GCTKGlucoTrack Inc
US$ 0.1027
(20.97%)
119.62M
ASSTAsset Entities Inc
US$ 1.02
(119.59%)
90.99M
HSDTHelius Medical Technologies Inc
US$ 1.44
(91.74%)
58.1M
RIMEAlgorhythm Holdings Inc
US$ 0.0364
(-12.50%)
30.96M